Category: Food and Drug Administration

Risk of Transmission of Superbugs during Gastrointestinal Endoscopy

Click here (PDF format) or here (HTML format) to read Dr. Muscarella’s “Risk of transmission of carbapenem-resistant Enterobacteriaceae and related ‘superbugs’ during gastrointestinal endoscopy” (World J Gastrointest Endosc 2014; 6(10):457-474.)…

Lessons Taught by a Recent “Superbug” Outbreak: Could ‘Ex Post Facto’ Notification be Warranted?

April 21, 2014 — Advocate Lutheran General Hospital (Park Ridge, IL) in 2013 linked multiple patient infections and colonizations of carbapenem-resistant Enterobacteriaceae, or “CRE,” to contaminated gastrointestinal (GI) endoscopes. This…

GI Endoscopy: Pushed Beyond its Reprocessing Limits?

This article is divided into two sections, for the reader’s convenience: “Part 1: ‘The Outbreak'” and “Part 2: ‘Commentary: An superbug outbreak waiting to happen?'” (‘Part 2’ can be read…